Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvia Rojo Rello

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Mbio|January 2, 2025
Are we serologically prepared against an avian influenza pandemic and could seasonal flu vaccines help us?Iván Sanz-Muñoz, Javier Sánchez-Martínez, Carla Rodríguez-Crespo, et al.
Emerging Infectious Diseases|February 2, 2023
Possible Mpox Protection from Smallpox Vaccine-Generated Antibodies among Older AdultsIván Sanz-Muñoz, Laura Sánchez-dePrada, Javier Sánchez-Martínez, et al.
Scientific Reports|January 3, 2024
Impact on the time elapsed since SARS-CoV-2 infection, vaccination history, and number of doses, on protection against reinfectionLaura Sánchez-de Prada, Ana María Martínez-García, Belén González-Fernández, et al.
European Journal of Pediatrics|May 16, 2025
Universal administration of nirsevimab in infants: an analysis of hospitalisations and paediatric intensive care unit admissions for RSV-associated lower respiratory tract infectionsLorena Bermúdez-Barrezueta, Vanesa Matías Del Pozo, José Manuel Marugán-Miguelsanz, et al.
Biomedicines|April 3, 2021
Growth Arrest-Specific Factor 6 (GAS6) Is Increased in COVID-19 Patients and Predicts Clinical OutcomeAlbert Morales, Silvia Rojo Rello, Helena Cristóbal, et al.
Virus Research|June 28, 2025
A 15-year study of neuraminidase mutations and the increasing of S247N mutation in SpainIván Sanz-Muñoz, Alejandro Martín-Toribio, Adrián García-Concejo, et al.
Cephalalgia : an International Journal of Headache|November 11, 2023
InfluenCEF study: Clinical phenotype and duration of headache attributed to influenza infectionDavid García-Azorín, Laura Santana-López, José Eugenio Lozano-Alonso, et al.
Human Vaccines & Immunotherapeutics|January 27, 2025
Disease burden of influenza in Spain: A five-season study (2015-2020)Iván Sanz-Muñoz, Irene Arroyo-Hernantes, Alejandro Martín-Toribio, et al.
Frontiers in Immunology|March 13, 2023
Evolution of antibody profiles against SARS-CoV-2 in experienced and naïve vaccinated elderly peopleIván Sanz-Muñoz, Rosa López-Mongil, Javier Sánchez-Martínez, et al.
Infectious Diseases and Therapy|July 21, 2024
RSV Risk Profile in Hospitalized Adults and Comparison with Influenza and COVID-19 Controls in Valladolid, Spain, 2010-2022Mariana Haeberer, Martin Mengel, Rong Fan, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Mbio|January 2, 2025
Are we serologically prepared against an avian influenza pandemic and could seasonal flu vaccines help us?Iván Sanz-Muñoz, Javier Sánchez-Martínez, Carla Rodríguez-Crespo, et al.
Emerging Infectious Diseases|February 2, 2023
Possible Mpox Protection from Smallpox Vaccine-Generated Antibodies among Older AdultsIván Sanz-Muñoz, Laura Sánchez-dePrada, Javier Sánchez-Martínez, et al.
Scientific Reports|January 3, 2024
Impact on the time elapsed since SARS-CoV-2 infection, vaccination history, and number of doses, on protection against reinfectionLaura Sánchez-de Prada, Ana María Martínez-García, Belén González-Fernández, et al.
European Journal of Pediatrics|May 16, 2025
Universal administration of nirsevimab in infants: an analysis of hospitalisations and paediatric intensive care unit admissions for RSV-associated lower respiratory tract infectionsLorena Bermúdez-Barrezueta, Vanesa Matías Del Pozo, José Manuel Marugán-Miguelsanz, et al.
Biomedicines|April 3, 2021
Growth Arrest-Specific Factor 6 (GAS6) Is Increased in COVID-19 Patients and Predicts Clinical OutcomeAlbert Morales, Silvia Rojo Rello, Helena Cristóbal, et al.
Virus Research|June 28, 2025
A 15-year study of neuraminidase mutations and the increasing of S247N mutation in SpainIván Sanz-Muñoz, Alejandro Martín-Toribio, Adrián García-Concejo, et al.
Cephalalgia : an International Journal of Headache|November 11, 2023
InfluenCEF study: Clinical phenotype and duration of headache attributed to influenza infectionDavid García-Azorín, Laura Santana-López, José Eugenio Lozano-Alonso, et al.
Human Vaccines & Immunotherapeutics|January 27, 2025
Disease burden of influenza in Spain: A five-season study (2015-2020)Iván Sanz-Muñoz, Irene Arroyo-Hernantes, Alejandro Martín-Toribio, et al.
Frontiers in Immunology|March 13, 2023
Evolution of antibody profiles against SARS-CoV-2 in experienced and naïve vaccinated elderly peopleIván Sanz-Muñoz, Rosa López-Mongil, Javier Sánchez-Martínez, et al.
Infectious Diseases and Therapy|July 21, 2024
RSV Risk Profile in Hospitalized Adults and Comparison with Influenza and COVID-19 Controls in Valladolid, Spain, 2010-2022Mariana Haeberer, Martin Mengel, Rong Fan, et al.
Pageof 4